Literature DB >> 27981513

Growth hormone and the heart in growth hormone deficiency-what have we learned so far?

Jörgen Isgaard1, Antonio Cittadini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27981513     DOI： 10.1007/s12020-016-1206-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

Review 1.  Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.

Authors:  Carmine Gazzaruso; Monica Gola; Ioannis Karamouzis; Raffaele Giubbini; Andrea Giustina
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

Review 2.  Optimizing gh therapy in adults and children.

Authors:  W M Drake; S J Howell; J P Monson; S M Shalet
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

3.  Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.

Authors:  R H Böger; C Skamira; S M Bode-Böger; G Brabant; A von zur Muhlen; J C Frolich
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  Growth hormone-induced blood pressure decrease is associated with increased mRNA levels of the vascular smooth muscle KATP channel.

Authors:  Asa Tivesten; Anna Barlind; Kenneth Caidahl; Natalia Klintland; Antonio Cittadini; Claes Ohlsson; Jörgen Isgaard
Journal:  J Endocrinol       Date:  2004-10       Impact factor: 4.286

5.  Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency.

Authors:  Y B Sverrisdóttir; M Elam; H Herlitz; B A Bengtsson; G Johannsson
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

6.  High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.

Authors:  J O Johansson; K Landin; L Tengborn; T Rosén; B A Bengtsson
Journal:  Arterioscler Thromb       Date:  1994-03

7.  Growth hormone-deficient adults are insulin-resistant.

Authors:  J O Johansson; J Fowelin; K Landin; I Lager; B A Bengtsson
Journal:  Metabolism       Date:  1995-09       Impact factor: 8.694

8.  Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.

Authors:  F L Hew; M Koschmann; M Christopher; C Rantzau; A Vaag; G Ward; H Beck-Nielsen; F Alford
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

9.  One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.

Authors:  Mara Boschetti; Sergio Agosti; Valeria Albanese; Laura Casalino; Claudia Teti; Gian Paolo Bezante; Claudio Brunelli; Manuela Albertelli; Diego Ferone
Journal:  Endocrine       Date:  2016-04-13       Impact factor: 3.633

Review 10.  GH and the cardiovascular system: an update on a topic at heart.

Authors:  Jörgen Isgaard; Michele Arcopinto; Kristjan Karason; Antonio Cittadini
Journal:  Endocrine       Date:  2014-06-28       Impact factor: 3.633
  10 in total
  1 in total

1.  Circulating levels of growth hormone in postural orthostatic tachycardia syndrome.

Authors:  Madeleine Johansson; Fabrizio Ricci; Janin Schulte; Margaretha Persson; Olle Melander; Richard Sutton; Viktor Hamrefors; Artur Fedorowski
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.